The PAR2 signal peptide prevents premature receptor cleavage and activation

PLoS One. 2020 Feb 20;15(2):e0222685. doi: 10.1371/journal.pone.0222685. eCollection 2020.

Abstract

Unlike closely related GPCRs, protease-activated receptors (PAR1, PAR2, PAR3, and PAR4) have a predicted signal peptide at their N-terminus, which is encoded by a separate exon, suggesting that the signal peptides of PARs may serve an important and unique function, specific for PARs. In this report, we show that the PAR2 signal peptide, when fused to the N-terminus of IgG-Fc, effectively induced IgG-Fc secretion into culture medium, thus behaving like a classical signal peptide. The presence of PAR2 signal peptide has a strong effect on PAR2 cell surface expression, as deletion of the signal peptide (PAR2ΔSP) led to dramatic reduction of the cell surface expression and decreased responses to trypsin or the synthetic peptide ligand (SLIGKV). However, further deletion of the tethered ligand region (SLIGKV) at the N-terminus rescued the cell surface receptor expression and the response to the synthetic peptide ligand, suggesting that the signal peptide of PAR2 may be involved in preventing PAR2 from intracellular protease activation before reaching the cell surface. Supporting this hypothesis, an Arg36Ala mutation on PAR2ΔSP, which disabled the trypsin activation site, increased the receptor cell surface expression and the response to ligand stimulation. Similar effects were observed when PAR2ΔSP expressing cells were treated with protease inhibitors. Our findings indicated that there is a role of the PAR2 signal peptide in preventing the premature activation of PAR2 from intracellular protease cleavage before reaching the cells surface. The same mechanism may also apply to PAR1, PAR3, and PAR4.

MeSH terms

  • Animals
  • COS Cells
  • Chlorocebus aethiops
  • Endopeptidases / metabolism
  • HEK293 Cells
  • Humans
  • Mutation, Missense
  • Protease Inhibitors / pharmacology
  • Protein Sorting Signals / physiology*
  • Receptor, PAR-1 / metabolism*
  • Receptor, PAR-2 / genetics
  • Receptor, PAR-2 / metabolism*
  • Receptors, Cell Surface
  • Trypsin / metabolism

Substances

  • Protease Inhibitors
  • Protein Sorting Signals
  • Receptor, PAR-1
  • Receptor, PAR-2
  • Receptors, Cell Surface
  • Endopeptidases
  • Trypsin

Grants and funding

Janssen Research & Development, LLC provided support in the form of salaries for authors [BL, GL, JW, JD, CK, AH, LW, JT, TL, CL, SS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.